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Traditionally, in India, the decoction of Black creeper, Ichnocarpus frutescens (L.) W. T. Aiton leaves is used to 
treatment diabetes mellitus. However, its molecular mechanisms of antihyperglycemic effects have not been completely 
studied. Due to the potential antidiabetic effect of I. frutescens, we hypothesized that the polyphonic extract might add to 
glucose uptake through improvement in the expression of genes of the glucose transporter (GLUT) family messenger RNA 
(mRNA) in the liver and adipose tissues. Experimentally, diabetes mellitus was induced in Wistar rats through i.p. injection 
of freshly prepared solution of streptozotocin (45 mg/kg). This was done 15 minutes after the administration of nicotinamide 
(120 mg/kg, ip). Serum level of insulin and C-peptide were analyzed using standard methods. Glucose metabolism by the 
hepatocytes and adipocytes were also analyzed by quantitative RT-PCR mRNA expression levels of phosphoenolpyruvate 
carboxykinase 1 (PCK1), GLUT2 in the hepatocytes, and GLUT4 in the adipocytes. The hemidiaphragm were also isolated 
and processed to study in-vitro peripheral glucose utilization. Results of the present investigation suggest that STZ-NA 
induced diabetes is associated with hyperglycemia, altered levels of PCK1 and glucose transporters gene expression as well 
as decreased levels of insulin and C-peptide. On the other hand, the outcome of the daily oral administration of PPE to STZ-
NA induced diabetic rats at different doses (150 and 300 mg/kg bodywt.) for 30 days supports our hypothesis by showing 
significant improvement of insulin levels, C-peptide level, downregulation of PCK1 and upregulation of GLUT (2, 4) 
mRNA expression levels when compared to those of diabetic rats. The administration of PPE had also increased the uptake 
of glucose by rat hemidiaphragm significantly. Findings from this study demonstrate that PPE enhances peripheral glucose 
uptake through glycogenesis pathway, mediated by upregulation of GLUT2 and GLUT4, and downregulation of PCK1. Our 
study suggests that the leaf of I. frutescens is a rich source of polyphenolic compounds, including those with an insulin-
sensitizing function that may have the potential for treating or managing diabetes or insulin resistance.  
Keywords: Antidiabetic, Antihyperglycemic, Ayurveda, Black creeper, Glucose transporters, Glucose utilization, GLUT, 
Herbal, Streptozotocin-nicotinamide 
Type 2 diabetes mellitus (T2DM) is a chronic and 
complicated metabolic disorder that has reached 
epidemic proportions with the estimated prevalence 
rates and trends escalating largely in developing 
countries. T2DM in people 20–79 years is further 
projected to increase to 629 million in 2045 compared 
to 425 million in 2017
1
. It is primarily associated with 
insulin secretory defects related to inflammation and 
metabolic stress among other contributors, including 
genetic factors. T2DM frequently goes undiagnosed 
for many years because hyperglycemia develops 
gradually and, at earlier stages, is often not severe 
enough for the patient to notice the classic diabetes 
symptoms. Nevertheless, even undiagnosed patients 
are at increased risk of developing macrovascular and 
microvascular complications
2
. 
Over a period of time, this sustained chronic 
hyperglycaemia could end in microvascular and 
macrovascular injury, which significantly affects  
the quality of life and life expectancy
3
. The American 
Diabetes Association and the European Association 
for the Study of Diabetes consensus report 
“Management of Hyperglycemia in Type 2 Diabetes, 
2018” recommends a patient-centered approach to 
choosing appropriate pharmacologic treatment of 
blood glucose
4
. However, in some instances, patients 
will require medication reduction or discontinuation. 
Common reasons for this include ineffectiveness, 
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intolerable side effects, expense, or a change in 
glycemic goals. Medicinal use of herbal medicine in 
the treatment and prevention of diseases including 
diabetes has a long history compared to conventional 
medicine
5
. Over the years, considerable progress has 
been made with traditional plant extracts and their 
active constituents in suppressing hyperglycemia,  
thus potentially alleviating the symptoms and 
complications of T2DM
6
. Traditionally, antidiabetic 
herbs and/or their active ingredients may accomplish 
this basic need. More than 200 species of medicinal 
herbs have antidiabetic properties which were 
assessed mostly by classical screening tests without 
excavating far for the exact molecular and cellular 
mechanisms
7
. Hanhineva et al.
8
 have demonstrated 
that plants rich in polyphenols may reduce the risk of 
T2DM and hyperglycaemia. Hence, rigorous 
preclinical studies are still required to confirm the 
molecular mechanism in decreasing hyperglycemia. 
The observation of preclinical studies could provide 
more evidence in the treatment of T2DM, and may 
further encourage development of polyphenol based 
herbal medicines. 
Enhancing or stimulating peripheral glucose 
utilization is one of the several mechanisms that could 
control hyperglycemia; therefore, an effort to treat 
T2DM should focus on this area. Fundamentally, 
numerous causes integrate to facilitate the glucose 
utilization process, comprising of the activation of 
GLUT-2 in the liver, GLUT-4 in adipocytes and 
skeletal muscles, as well as induction of peroxisome 
proliferator-activated receptor-gamma (PPARγ)9. 
However, earlier investigations of Udea et al.
10
, have 
focused on insulin-sensitive GLUT4 and GLUT2 as 
novel targets of polyphenol compounds. Several 
investigators found that the increase in glucose uptake 
was associated with glucose transporters in the  
liver (GLUT2), adipose tissues and skeletal muscles 
(GLUT4) in experimental type 2 diabetic rats
11 
As a 
result, the role of some GLUT transporters gene 
expressions and the importance of these expressions 
have been studied in this experiment. Similarly, 
phosphoenolpyruvate carboxykinase (PEPCK/PCK1) 
is another rate-limiting enzyme of gluconeogenesis 
and enhanced expression of the PEPCK gene in the 
liver is present in most models of diabetes and is 
thought to contribute to the increased hepatic glucose 
output seen in diabetes
12
. PCK1 expression levels and 
regulation have been shown to be a sensitive marker 
for blood glucose levels. Alternatively, insulin 
strongly represses PEPCK transcription through the 
activation of the phosphoinositide-3 kinase (PI3K) 
pathway
13
. The primarily metabolic abnormality in 
insulin-resistant type 2 diabetics is due to defective 
regulation of glucose transporter genes, understanding 
these genes’ regulated (decreased/increased) expression 
may prove useful in the characterization of the major 
causes that lead to the development of diabetes 
mellitus. The compounds that are able to repress 
PEPCK expression and overcome insulin resistance 
could constitute a new class of glucose-lowering 
agents. Thus any medicine with the potential to alter 
hepatic gluconeogenesis or glycogenolysis or glucose 
utilization/uptake process might have a significant 
influence on glucose homeostasis in diabetes mellitus. 
The leaves of Black creeper, Ichnocarpus frutescens 
(Apocynaceae) have been used extensively in the form 
of decoction by the tribes in Karnataka and Utter 
Pradesh states for the treatment of diabetes and 
jaundice
14
. Due to the presence of active polyphenolic 
and flavonoid compounds in Apocynaceae family 
species, I. frutescens has been considered as a 
motivating choice to be studied further on its 
antihyperglycemic mode of action. Phenolic acids and 
terpenoids and flavonoids were three major classes of 
the chemical constituents of Ichnocarpus frutescens 
leaves. Babita et al.
15
, I. frutescens has been shown  
to contain several flavonoids and polyphenolic 
compounds
15
. Interestingly, various parts of I. frutescens 
have been shown to have hepatoprotective, antioxidant, 
antihyperlipidemic and antidiabetic activities
16-18
. 
Despite its reported use, no systematic study related to 
its molecular mechanism of action has been carried out 
in diabetic animals. In this study, to ascertain the 
molecular mechanism of actions of this plant in the 
management of diabetes, we investigated the insulin-
mimetic effect of polyphenolic extract of Ichnocarpus 
frutescens on the molecular mechanisms of glucose 
utilization on STZ-induced diabetic rats and normal rat 
hemidiaphragm tissues. 
 
Materials and Methods 
 
Plant Materials 
Fresh leaves of Ichnocarpus frutescens (L.) R.Br. 
were collected from the delta region of Cauvery 
River, Thiruchirappalli, Tamil Nadu, India, and was 
authenticated at the Botanical Survey of India (BSI), 
Central National Herbarium (CNH), Howrah, India. 
An authentic voucher specimen was deposited in the 
Herbarium Division of Pharmacognosy, Department 
of Pharmaceutical Technology, Jadavpur University, 
Kolkata, India. 
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Preparation of Polyphenolic Extract (PPE) 
Dried leaves of I. frutescens (500 g) were finely 
powdered, mixed with 70%
 
methanol and kept at 
room temperature (~25°C for 5 days. After 5 days
 
it 
was filtered and the solvent was evaporated. The 
residue
 
was dissolved in water and the aqueous layer 
was washed with
 
petroleum ether several times until a 
clear upper layer of petroleum
 
ether was obtained. The 
lower layer was then treated with ethyl
 
acetate 
containing glacial acetic acid (10 mL/L). Extraction
 
of 
polyphenols was carried out for 36 h at room 
temperature
 
and the combined ethyl acetate layer was 
concentrated. The residue was lyophilized and  
stored at 70°C. The total polyphenolic content and 
flavonoid of the extract were assayed using the 
standard methods
19
. 
 
Animals and ethical approval 
Healthy male Wistar albino rats, weighing about 
200-250 g/body wt. were used in this experiment. 
Animals were collected from the standard breeding 
colony from our university’s animal house and 
acclimatized to the laboratory condition for two 
weeks. They were housed in macrolon cages under 
standard laboratory conditions (light period 7.00 am. 
to 7.00 pm, 21±2ºC, and relative humidity 55-70 %). 
The animals were fed with standard commercial diet 
and free access to water (ad libitum) during the 
experiment. Experiments performed complied with 
the rulings of the Institutional Animal Care and the 
study was permitted by the Institutional Animal 
Ethical Committee (IAEC). 
 
Induction of experimental diabetes mellitus 
A freshly prepared solution of streptozotocin  
(45 mg/kg) in 0.1M citrate buffer, pH 4.5, was 
injected i.p. in a volume of 0.1 mL/kg, 15 min after 
the administration of 120 mg/kg nicotinamide 
according to the methods previously reported
20
. After 
48 h of streptozotocin administration, rats with 
moderate diabetes having glycosuria and hyperglycaemia 
(i.e., with a blood glucose of 200-300 mg/dL) were 
taken for the experiment. The blood elevated glucose 
levels were determined at 72 h and then 7 days after 
injection, to simulate hyperglycemia. Rats that were 
found with constant values of elevated glucose levels 
were used for the study.  
 
Experimental design  
In the experiment, a total of 30 rats (24 diabetic 
surviving rats, 6 normal rats) were used. The rats were 
divided into five groups of six rats each. Two 
different doses of PPE (150 and 300 mg/kg/day) were 
administered orally for 30 days. All the doses were 
initiated 48 h after the elevation of blood glucose 
followed by STZ-NA injection. At the end of the  
30 days, all the rats were killed by decapitation 
(pentobarbitone sodium) under anaesthesia (60 mg/kg). 
All animals received human care, according to the 
guidelines set by the World Health Organization 
(WHO), Geneva, Switzerland, and the Institutional 
Animal Ethical Committee. 
 
Measurement of C-peptide and insulin levels 
Blood samples (approximately 0.5 mL) collected 
from the retro-orbital venous plexus using hematocrit-
capillary tubes containing heparin were centrifuged at 
10000 rpm at 4ºC for 10 min. Plasma samples  
were then stored at –20ºC. Plasma insulin level was 
assayed by Mercodia Rat Insulin ELISA kit (Sweden) 
from the plasma collected on the day of sacrifice
21
. 
The optical density for the reading of the sample was 
set to 450 nm. The concentration of insulin level was 
obtained by computerized data reduction of the 
absorbance for the calibrators, except for Calibrator 0, 
versus the concentration using cubic spline regression. 
The insulin level of the samples was calculated using 
the formula generated. Plasma C-peptide level was 
assayed according to the standard method by 
Mercodia Rat C-peptide ELISA kit (Sweden) from the 
plasma obtained from retro-orbital puncture
22
. The 
optical density for the reading was also set to 450 nm. 
The concentration of C-peptide was obtained using 
cubic spline regression the same way as the Insulin 
ELISA kit mentioned above. 
 
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) 
Total RNA was isolated from liver and adipose 
tissues by TRI reagent solution (Ambion, Austin, 
Texas, USA) according to the manufacturer’s 
instructions. The total RNA concentration was 
determined by measuring the absorbance at 260 nm. 
The purity of the extracted RNA was determined by 
measuring the ratio of the optical density at 260 and 
280 nm using a spectrophotometer (BioRad, USA), 
ranging between 1.8 and 2.0 according to earlier 
described method
23
. Briefly, a reaction volume of  
25 μL contained 12.5 μL master mix, 1 μL of 5 M 
each forward and reverse primers, and 1 μL of the 
template RNA at a concentration of 100 ng under the 
following conditions: 42°C for 30 min (this step was 
included to synthesize cDNA), 95°C for 10 min,  
40 cycles at 95°C for 15 s, 53°C for 30 min and 72°C 
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for 4 s. Data were acquired on SYBR channel at the 
end of each extension step. Melt curves were analyzed 
to check for the absence of mispriming. The 
possibility of a genomic DNA influence on the results 
was eliminated by the use of primers. Primers specific 
for GLUT2, GLUT4, PCK1 and β-actin genes were 
designed from the gene sequence of rat (Rattus 
norvegicus) adopted from NCBI (National Center for 
Biotechnology Information) GenBank Database 
(www.ncbi.nlm.nih.gov) and supplied by NextGene. 
The run was performed using Sensi Mix one-step RT-
PCR kit with SYBR Green (Quantace, London, UK) 
according to manufacturer's instructions. Each 
experiment was performed three times. Expression 
levels for each gene relative to beta-actin were 
calculated for all samples using the Rotor-Gene 
software (Version 1.7, Corbett Research) and 
Microsoft Excel. Analysis of gene expression data 
was carried out by the CT method of relative 
quantification according to the methods previously 
reported
24
. Forward and reverse primer sequences 
were: Forward primer: 5´ ATGGTGGGTATGGG 
TCAG 3´ and reverse primer: 5´ CAATGCCGTGT 
TCAATGG 3´ for ACTB; forward primer: 5´ 
TCTGTGCTGCTTGTGGAG 3´ and reverse: 5´ 
CTGACGAAGAGGAAGATGG 3´, for GLUT2; 
forward primer: 5´ AACGTTGGCTGGCTCTC 3´ 
and reverse: 5´GAACCTGGCGTTGAATGC3´ for 
PCK1; forward primer: 5´ GCCTTCTTTGAGA 
TTGGTCC6] 3´ and reverse: 5´ CTGCTGTTTCCT 
TCATCCTG 3´, for GLUT4. 
 
Effect on glucose utilization by rat hemidiaphragm 
Glucose uptake by rat hemidiaphragm was 
estimated using the previously reported methods with 
minor modifications
25
. Four sets containing six 
graduated test tubes (n=6), were taken as follows: 
Group I, 2mL of Tyrode solution with 2% glucose; 
Group II, 2 mL of Tyrode solution with 2% glucose 
and regular insulin (Nova Nordisk) 0.62 mL of  
0.4 units per mL solution; Group III, 2mL of Tyrode 
solution and 1.38 mL of PPE (0.1%); and Group IV,  
2 mL of Tyrode solution with 2% glucose and regular 
insulin 0.62 mL of 0.4 units per mL solution and  
1.38 mL of PPE (0.1%). The volumes of all the test 
tubes were filled with 4 mL of distilled water to 
match the volume of the test tubes of Gr. IV. Twelve 
albino rats were fasted overnight and killed by 
decapitation. The diaphragms were dissected out 
quickly with minimal trauma and divided into two 
halves. Two diaphragms from the same animal were 
not used for the same set of experiment. Six diaphragms 
were used for each group. The hemidiaphragm were 
placed in test tubes and incubated for 30 min at 37°C 
in an atmosphere of 100% oxygen with shaking at 140 
cycles/min. Glucose uptake per gram of tissue was 
calculated as the difference between the initial and 
final glucose content in the incubated medium. 
 
Statistical analysis 
The experimental data were expressed as mean  
SEM. The significance of difference among the 
various treated groups and control group were 
analyzed by means of one-way and two-way ANOVA 
followed by Dunnett’s multiple comparisons and 
Bonferroni post-hoc test, respectively using GraphPad 
Prism Software (San Diego, USA). P <0.05 was 
considered as statistically significant. 
 
Results 
Diabetic rats treated with PPE for 30 days displayed a 
notable improvement in plasma insulin and C-peptide 
levels as compared to untreated STZ-diabetic rats. 
Plasma insulin and C-peptide were analyzed to check 
the appropriate endogenous insulin release from β-cells 
after PPE treatment. Fig. 1 A and B illustrate the effect 
 
 
Fig. 1 — Effect of polyphenolic extract of I.frutescens on insulin 
(A); and C-peptide (B) levels in streptozotocin-nicotinamide 
induced diabetes after 30 days of drug treatment. [Values are 
expressed as mean ± S.E.M of six rats (n=6). Statistically different 
from control, *** P <0.001, **P <0.01] 
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of the polyphenolic extract on plasma insulin and  
C-peptide levels, respectively in normal and experimental 
animals.  
The in vivo effect of PPE on gene expression of 
GLUT4, GLUT2 and PCK1 was performed by RT-PCR 
using respective specific primers. In the present study, 
hepatic GLUT2 expression was lower in control of 
diabetic rats, but the expression was significantly  
(P <0.001 and P <0.01)) higher in the treated groups. 
This suggests that the expression of hepatic GLUT2  
may also be triggered by insulin secretion. Significant 
improvement was observed in the expression of GLUT2 
from the liver and the GLUT4 from the adipocytes  
in response to glucose uptake (Fig. 2 A and B).  
The treatment with PPE significantly reduced the 
expression of the genes encoding the regulatory enzyme 
of gluconeogenesis and phosphorylation (PCK1) in the 
liver of diabetic rats. The current study thus reveals that 
PPE significantly (P <0.001) represses hepatic PCK1 
gene expression in diabetic rats compared to diabetic 
control rats (Fig. 3).  
Fig. 4 illustrates glucose uptake (mg/g tissue wt./ 
30 min) by isolated rat hemidiaphragm muscle in the 
absence and presence of insulin and PPE. Glucose 
uptake by isolated rat hemidiaphragm muscle of 
control groups in the presence of insulin (0.4 U/mL) 
 
 
Fig. 2 — Effect of polyphenolic extract on the mRNA level of 
GLUT2 (A); and GLUT4 (B) genes in diabetic rat liver and 
adipose tissues, respectively by quantitative RT-PCR analysis. 
[The number of products for each sample was measured according 
to the quantity of β-actin while the number of fold expression was 
calculated by 2-ΔΔCt. Values are expressed as mean ± S.E.M of six 
rats. Statistically different from control, *** P <0.001, **P <0.01] 
 
 
Fig. 3 — Effect of polyphenolic extract on the mRNA level of 
PCK-1 gene expression in diabetic rats by quantitative RT-PCR 
analysis. [The number of products for each sample was measured 
according to the quantity of β-actin while the number of fold 
expression was calculated by 2-ΔΔCt. Values are expressed as mean 
± S.E.M of six rats. Statistically different from control,  
*** P <0.001, **P <0.01] 
 
 
 
Fig. 4 — Effect of polyphenolic extract of I. frutescens on glucose 
uptake in rat hemidiaphragm. [*P < 0.01 significant when 
compared to control glucose in the incubation medium. Values are 
expressed as mean ± S.E.M of three different hemidiaphragm 
tissues (n=3). Statistically different from control, *** P <0.001, 
*P <0.05] 
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was significantly higher (15.75 ± 2.25 mg/g tissue 
wt./30 min) than in the absence of insulin (5.70 ± 
0.695 mg/g tissue weight/30 min). PPE (0.1%) treated 
rat hemidiaphragm muscles showed significant  
(P <0.001) glucose uptake (43.65 ± 3.60 mg/g tissue 
wt./30 min) when compared to control and insulin 
treatment alone (P <0.05). The ex-vivo study on 
glucose utilization/uptake by isolated rat hemidiaphragm 
revealed that glucose uptake by the PPE is 
significantly higher than that of insulin. Thus, overall 
glucose utilizing process and glycogen synthesis 
(glycogenesis) stimulated by PPE is significantly 
more effective than insulin. The combination of PPE 
and insulin showed a marked increase in glucose 
uptake by rat hemidiaphragm.  
 
Discussion 
Non-insulin dependent diabetes mellitus is 
characterized by abnormal β-cell function caused by 
chronic hyperglycemia
26
. The fundamental mechanism 
underlying chronic hyperglycemia in a diabetic patient 
involves excessive production and decreased uptake  
of glucose by the tissues. Controlling the postprandial 
blood glucose excursions can prevent chronic 
hyperglycaemia and improve insulin resistance
27
. 
Glucose uptake in peripheral tissues is largely mediated 
by a group of intrinsic membrane proteins known as 
facilitative glucose transporters
28
. Maintenance of 
glucose homeostasis depends on insulin by inhibiting 
expression of PCK1 enzyme and stimulating expression 
of GLUT2 and GLUT4 transporters. The GLUT4 
expression is downregulated when there is a relative 
insulin deficiency, such as in STZ-induced diabetes
29
. 
Consequently, decreased utilization of glucose by the 
peripheral tissues results in the elevation of fasting blood 
glucose. Since the amelioration of abnormal glucose 
metabolism in diabetes mellitus is shown to be largely 
due to an increase in the glucose uptake in muscle and 
adipose tissues, the alteration in GLUT transporters 
expression or their translocation to the plasma 
membrane is regarded as a possible target in the 
treatment of diabetes mellitus
30
. For this reason, we 
investigated whether PPE improves GLUT2 in the liver 
or GLUT4 expression in insulin-sensitive adipose 
tissues. In addition, we have also investigated the effects 
of PPE on glucose uptake by isolated rat hemidiaphragm 
tissues. Therefore, we hypothesized that PPE may 
improve hyperglycemia and insulin resistance by 
ameliorating impaired GLUT2 expression in liver and 
GLUT4 expression in adipose tissues from STZ-NA 
induced diabetic rats. 
STZ induced hyperglycemia in rodents is 
considered to be a good preliminary screening method 
and is most widely used. STZ enters the B cell via a 
glucose transporter (GLUT2) and causes alkylation of 
DNA. STZ induced hyperglycemia may be attributed 
to the enhancement of gluconeogenesis as a result  
of the absence of insulin
31
. Repeated (30 days) 
administration of the PPE improved plasma insulin 
and C-peptide levels in the STZ-NA induced diabetic 
rats compared with control diabetic rats. The anti-
hyperglycemic effects revealed by the PPE against 
STZ-NA induced hyperglycemia were relatively 
similar to that of standard reference drug, metformin. 
Glucose uptake in peripheral tissues is dependent 
on the translocation of GLUT4 glucose transporters to 
the plasma membrane. Numerous peripheral tissues 
play an important part in maintaining blood glucose 
homeostasis. Amongst these, the liver, pancreatic  
β-cells, skeletal muscle and adipose tissue are of 
greatest importance since they can sense and respond 
to varying blood glucose levels. Glucose is taken up 
into the cell through GLUT2 and GLUT4 in the 
plasma membrane of the cells
32
. Changes in these 
glucose transporters gene expressions are an 
important component of the pathogenesis of diabetes. 
In recent years, numerous plant extracts and plant 
formulations have been shown to regulate the 
expression of genes in metabolic pathways of 
different diabetic animal models
33
. In diabetic 
subjects, GLUT-2 and GLUT-4 expression are 
decreased before the loss of glucose-stimulated 
insulin secretion
34
. First, we showed that there are 
marked increases in fasting blood glucose level in 
STZ-NA diabetic rats and impaired glucose tolerance 
in the normal vehicle control rats. Consistent with 
earlier reports, we also showed that the GLUT4 
expression in adipose tissue is drastically diminished 
in diabetic rats, as compared with vehicle control. 
Previous reports suggest that GLUT4 gene expression 
is down-regulated in STZ-induced diabetes, a state of 
insulin deficiency. A decrease in the GLUT4 mRNA 
was observed in STZ-NA induced diabetic animals 
which account for the impaired glucose disposal
35
. 
The principal glucose transporter protein that 
mediates this uptake is GLUT4, which plays a key 
role in regulating whole-body glucose homeostasis
36
. 
Our reports support the present study, which 
demonstrated a decrease in GLUT4 expression in 
adipose tissue of STZ-induced diabetic rats. Our 
previous studies have reported the antidiabetic effect 
polyphenolic extract of I. frutescens in STZ-NA 
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induced diabetes in rats
37
, while the mode of action of 
this plant is not yet reported. 
The current results from our current investigation 
confirm that hyperglycemia and impaired glucose 
tolerance are at least in part due to a decreased 
expression of these GLUT proteins. Since, both 
GLUT2 and GLUT4 are expressed in liver and 
insulin-sensitive tissue such as adipose, and they 
participate in the basal and insulin-stimulated glucose 
uptake. Interestingly, PPE treatment improves 
hyperglycemia and impaired glucose tolerance 
observed in STZ-NA diabetic rats. Our previous 
evidence has also suggested that PPE significantly 
inhibited postprandial excursion in experimental rats. 
Moreover, the circulating C-peptide and insulin levels 
were restored back to normal in PPE treated rats. An 
important finding in the current present investigation 
is that the mRNA expression of GLUT4 in adipose 
tissue and GLUT2 expression in liver from diabetic 
rats is dramatically increased by PPE. Therefore,  
the beneficial effect of PPE on STZ-NA induced 
hyperglycemia may be due to a remarkable 
improvement of GLUT4 and GLUT2 expression in 
adipose tissue and liver, respectively. Thus, increasing 
the expression of hepatic GLUT2 might add another 
efficient mechanism of PPE through response to 
insulin action. Taken together, the results from this 
study suggest that the modulation of GLUT2 and 
GLUT4 mRNA expression could thus be one of the 
mechanisms of the anti-hyperglycemic potential of 
PPE of I. frutescens leaves. 
In this line, our results suggest that PPE could more 
efficiently contribute towards promoting glucose 
uptake from the blood when glucose levels are 
postprandially elevated in comparison with diabetic 
rats, as described for metformin. The investigation 
also revealed a significant increase in serum insulin 
and C-peptide level in rats treated with PPE and 
metformin. Thus, the antidiabetic effect of PPE could 
be attributed to upregulation of these protein 
expressions resulting in potentiation of pancreatic 
secretion of insulin from existing β-cells of islets. 
Overall, PPE has been demonstrated to have an 
insulin-like effect on glucose uptake
38
. PEPCK is one 
of the major enzymes responsible for the regulation of 
gluconeogenesis. In addition, phosphoenolpyruvate 
gluconeogenesis and hepatic glucose production have 
been found to be increased in diabetic
39
. It has also 
been shown that PPE significantly inhibited the 
expression of PCK-1 in diabetic rats. In agreement 
with our results, the phenolic compounds in PPE 
reduced the levels of this gluconeogenic enzyme 
(PEPCK) mRNA expression in the liver during  
STZ-NA induced hyperglycemia situation and, 
consequently, reduced blood glucose level. PEPCK 
overexpression restoration by PPE reflects increased 
insulin sensitivity in STZ diabetic rats. Over the 
years, scientific evidence has strongly supported that 
the polyphenolic compounds improve hyperglycaemic 
status through enhanced the expression of AMPK and 
GLUT4
40
. Additionally, it has been observed that 
flavonoids restore 5'AMP-activated protein kinase 
(AMPK) and GLUT4 expression in skeletal muscle 
and adipose tissues in high-fat diet-induced obese 
mice
41
. However, additional molecular mechanistic 
studies are needed to define the detailed role of PPE 
in the regulation of the insulin pathways, other 
glucose transporters and glucose utilization in other 
peripheral tissues.  
In addition, the possibility of enhanced 
hemidiaphragm tissues uptake of glucose by PPE 
treatment cannot be ruled out. The estimation of 
glucose content in the rat hemidiaphragm is a 
commonly employed and reliable method for in vitro 
study of peripheral uptake of glucose. Furthermore, 
the glucose reducing effect of PPE was more 
significant when compared to normal rats, suggested 
that it could be caused by an increase in peripheral 
glucose utilization; this reinforces the hypothesis that 
the hypoglycemic mechanism involves insulin-like 
effect through peripheral glucose uptake by PPE.  
A decrease in blood glucose may be attributed to the 
stimulation of glucose uptake by peripheral tissue and 
a decrease in the gluconeogenesis. It appears that  
PPE has direct peripheral action by promoting  
glucose utilization of skeletal muscle. Several herbal 
preparations increase the beta cell regeneration and 
peripheral tissue glucose utilization in streptozotocin-
induced diabetic animal supports the above hypothesis
42
. 
Our in vitro studies also showed that PPE significantly 
increased glucose uptake in rat hemidiaphragm 
tissues. These results indicate that the inhibition in 
liver gluconeogenesis process and the enhancement in 
adipocyte tissue glucose uptake are involved in the 
PPE induced antihyperglycemic action.  
These observations suggest a possible role for 
polyphenolic compounds of I. frutescens in  
regulation hyperglycemia, although the effects  
appear to be the result of direct action on peripheral 
tissue. However, since unpurified extracts were used, 
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it is not possible to assign the effects to any particular 
compounds(s). To conclude, the data presented in this 
investigation support our primary hypothesis that  
the antihyperglycemic action of the polyphenolic  
extract of I. frutescens comprises an array of actions 
and provides direct evidence for the involvement  
of GLUT4 in controlling glucose homeostasis. Lastly, 
with a better understanding of insulin signalling 
pathways, it would be possible to assess, exactly and 
molecularly, the importance of PPE on glucose uptake 
and homeostasis. Furthermore, it would be possible to 
assess the action of PPE that might optimize glucose 
uptake and consequently be an important step in 
controlling the blood glucose levels.  
 
Conclusion 
In vivo antidiabetic effects of the polyphenol extract 
from the Ichnocarpus frutescens leaves were studied  
in nicotinamide-streptozotocin induced diabetic  
animal model. Our experimental data has shown that 
administration of the polyphenol extract to diabetic rats 
enhances peripheral glucose utilization by activating 
glucose GLUT2 and GLUT4 gene expression while 
downregulating PCK1 gene expression in liver. 
According to the present study, PPE of I. frutescens 
possesses a potent antidiabetic activity and could be 
used as a safe remedy for the treatment of diabetes 
mellitus. While the effects of I. frutescens polyphenol 
extracts are important as it is derived from an established 
herbal medicine used for human consumption, the side 
effects from prolonged polyphenol extract administration 
as described herein need to be completely assessed. 
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